O
NVO

OppenheimerFunds’s Novo Nordisk NVO Stock Holding History

OppenheimerFunds’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-3,787,620
Closed -$80.1M – 932
2014
Q4 		$80.1M Sell
3,787,620
-2,120
-0.1% -$47.4K 0.09% 246
2014
Q3 		$90.2M Buy
+3,789,740
New +$87.2M 0.1% 222
2013
Q4 		– Sell
-3,610,740
Closed -$61.1M – 941
2013
Q3 		$61.1M Sell
3,610,740
-1,955,100
-35% -$32.9M 0.08% 285
2013
Q2 		$86.3M Buy
+5,565,840
New +$92.6M 0.12% 204

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

OppenheimerFunds's NVO Position: Q1 2015 in Review

OppenheimerFunds sold out of Novo Nordisk (NVO) in Q1 2015, closing a stake of 3,787,620 shares — an estimated $80.1M sold.

OppenheimerFunds first reported a position in NVO in Q2 2013 and held it in 4 quarters. The position peaked at $90.2M in Q3 2014. 505 funds tracked by Wall St. Rank hold NVO as of Q1 2015.

  • OppenheimerFunds reported no remaining Novo Nordisk position as of Q1 2015 after selling out during the quarter.
  • OppenheimerFunds sold 3,787,620 Novo Nordisk shares in Q1 2015, an estimated $80.1M.
  • OppenheimerFunds first reported a position in Novo Nordisk in Q2 2013 and held it in 4 quarters.
  • OppenheimerFunds's Novo Nordisk position peaked at $90.2M in Q3 2014.
  • 505 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2015.

Based on OppenheimerFunds's 13F filing for Q1 2015, filed 15 May 2015.